Menu
Not yet recruiting NCT07135024

Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict

Observational Trigeminal Neuralgia Tic Douloureux Facial Pain Glossopharyngeal Neuralgia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Trigeminal Neuralgia, Tic Douloureux, Facial Pain, Glossopharyngeal Neuralgia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany, Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of the registry is a multicenter, prospective long-term data collection of patients suspected neurovascular conflict and referred for possible microvascular decompression (Jannetta procedure). The registry relies exclusively on routinely collected clinical data, which are gathered in a standardized and privacy-compliant manner as part of everyday clinical practice. By systematically compiling this information across multiple centers, valuable insights into the effectiveness, potential side effects, and long-term outcomes of this surgical treatment can be gained. The registry will serve as a foundation for future scientific analyses and is intended to help answer relevant research questions regarding the treatment of trigeminal neuralgia based on solid evidence.

Primary outcome measures

  • Pain relief after surgical treatment [Time frame: From enrolment to last follow-up 5 yrs after surgery]
  • Face specific pain relief after surgical treatment [Time frame: From enrolment to last follow-up 5 yrs after surgery]
Secondary outcome measures (4)
  • Surgical complications [Time frame: three months after index surgery]
  • Need for additional treatment [Time frame: 5 years after index surgery]
  • Patient satisfaction [Time frame: 5yrs after index surgery]
  • Effect of surgical treatment on quality of life [Time frame: 5 years after index surgery]

Eligibility criteria

Inclusion criteria

  • suspected neurovascular conflict
  • signed consent for further use of routine clinical data as accepted by local regulations

Exclusion criteria

  • refusal of further use of routine clinical data

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Germany · 1 center
  • Dept. of Neurosurgery, RWTH Aachen University Hospital, RWTH Aachen University — Aachen
Switzerland · 1 center
  • Dept. of Neurosurgery, Cantonal Hospital Aarau — Aarau

Identifiers

NCT: NCT07135024 · PETER registry

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗